HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Proposed Calif. Phthalates Ban Revived; Headed To Senate Floor

This article was originally published in The Rose Sheet

Executive Summary

Legislation introduced by California Assembly member Judy Chu (D-49th) seeking to prohibit the manufacture or distribution of personal care products containing phthalates likely will be addressed on the California State Senate floor in August, according to Chu staffers

You may also be interested in...



Cosmetics Industry Loses California Battle; Ingredient Bill Becomes Law

The Cosmetic, Toiletry and Fragrance Association will work with the California Department of Health Services to implement provisions of the California Safe Cosmetics Act, the association says. Despite rigorous opposition by CTFA, among others, Gov. Arnold Schwarzenegger (R) signed the bill into law Oct. 7

Cosmetics Industry Loses California Battle; Ingredient Bill Becomes Law

The Cosmetic, Toiletry and Fragrance Association will work with the California Department of Health Services to implement provisions of the California Safe Cosmetics Act, the association says. Despite rigorous opposition by CTFA, among others, Gov. Arnold Schwarzenegger (R) signed the bill into law Oct. 7

CTFA 2005 Action Plan Aims To Reinforce Industry Credibility

The Cosmetic, Toiletry and Fragrance Association is implementing a multi-pronged action plan in 2005 to address cosmetic safety concerns and reinforce the industry's credibility with consumers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012271

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel